New tear film technologies join the fight against dry eye

Article

Clinically friendly technology for the evaluation of the tear film will play an increasing role in helping optometrists diagnose and treat dry eye disease.

"In the realm of tear film evaluation, there has been very little that has come our way that has been clinically friendly," said Dr. Bitton, associate professor and externship director, University of Montreal School of Optometry, Montreal, Canada.

"There have been numerous technological advances available for research, but they often require substantial technical expertise, dedicated space, and are costly, rendering them impractical for use in most clinical practices," she noted.

Traditional methods

According to Dr. Bitton, most optometrists are very comfortable with these traditional tests, although most are subjective in nature and provide limited information on their own. Of all the tear film technologies becoming available, she believes it's most likely that clinicians will embrace the os-mometer, which is compact and clinically friendly.

The most recent osmometer (TearLab Os-molarity System, TearLab Corp.) uses a microchip to measure the concentration, or osmolarity, of a small tear sample, Dr. Bit-ton said. A comparative chart allows the clinician to assess the severity of the dry-ness from the osmolarity value obtained.

"This is a completely objective test that can not only help the clinician assess dry-ness at the onset, but can also follow the progress of the treatment of the dry eye patient," she said. "It eliminates subjectivity. The device provides a number so optometrists and patients can follow the progress of that number, just like a cholesterol or blood pressure number.

"The test is quick, reliable, and doesn't take a lot of chair time," Dr. Bitton added. "Most of the other technologies require technical support and expertise, take longer to obtain a result from a tear sample, and require much larger samples, which can be difficult to obtain in patients with dry eye."

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.